VRS
CRBP icon

Virginia Retirement Systems’s Corbus Pharmaceuticals CRBP Stock Holding History

Virginia Retirement Systems’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-957
Closed -$241K – 1100
2020
Q2 		$241K Buy
+957
New +$193K ﹤0.01% 996

Other funds holding CRBP

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Virginia Retirement Systems's CRBP Position: Q3 2020 in Review

Virginia Retirement Systems sold out of Corbus Pharmaceuticals (CRBP) in Q3 2020, closing a stake of 957 shares — an estimated $241K sold.

Virginia Retirement Systems first reported a position in CRBP in Q2 2020 and held it in 1 quarter. The position peaked at $241K in Q2 2020. 122 funds tracked by Wall St. Rank hold CRBP as of Q3 2020.

  • Virginia Retirement Systems reported no remaining Corbus Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Virginia Retirement Systems sold 957 Corbus Pharmaceuticals shares in Q3 2020, an estimated $241K.
  • Virginia Retirement Systems first reported a position in Corbus Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Virginia Retirement Systems's Corbus Pharmaceuticals position peaked at $241K in Q2 2020.
  • 122 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2020.

Based on Virginia Retirement Systems's 13F filing for Q3 2020, filed 12 Nov 2020.